Correlation of proteomics-identified targetswith clinical data in ACC using GEPIA revealed that SRRM2, NUP160,and RBM3 are associated with shorter OS, DFS, and advanced stage (Figure S2). The gene discussed is RBM3; the disease is adrenal cortex carcinoma.